Aspirin and its Metabolites Enhance the Expression of Vascular Endothelial Growth Factor in Retinal Pigment Epithelial Cell Cultures – Implications in the Pathophysiology of Age-Related Macular Degeneration by Iqbal O et al.
Iqbal O, et al., (2015) Aspirin and its Metabolites Enhance the Expression of  Vascular Endothelial Growth Factor in Retinal Pigment Epithelial Cell Cultures – Implica-
tions in the Pathophysiology of  Age-Related Macular Degeneration. Int J Ophthalmol Eye Res.  03(7), 115-120. 115
http://scidoc.org/IJOES.php
Aspirin and its Metabolites Enhance the Expression of  Vascular Endothelial Growth Factor in 
Retinal Pigment Epithelial Cell Cultures – Implications in the Pathophysiology of  Age-Related             
Macular Degeneration
                                       Case Study
Iqbal O1*, Brambl W2, Ottman A2, O'Malley P6, Gaynes J4, De Alba F3, Gaynes B3, Fareed J5, Bouchard CS7
1 Professor of  Pathology & Ophthalmology, Loyola University Medical Center, USA.
2 Research Scholar, Stritch School of  Medicine, Loyola University Chicago, USA.
3 Professor of  Pathology & Ophthalmology, Loyola University Medical Center, USA.
4 Research Assistant, Masonic Cancer Center, University of  Minnesota, USA.
5 Professor, Department of  Pharmacology & Pathology, Loyola University Health System, Maywood, USA.
6 Research Scholar, Department of  Ophthalmology, Loyola University Medical Center, USA.
7 Professor of  Ophthalmology, Loyola University Health System, Maywood, USA.
Introduction
Age-related macular degeneration (AMD) is the leading cause of  
adult eye disease among industrialized nations, particularly in the 
elderly [1]. Clinically, there is a critical unmet need in the treatment 
of  this condition essentially due to the lack of  proper understand-
ing of  disease pathophysiology. The US, Canada, and Cuba spend 
approximately US$98 Billion in direct healthcare costs for visual 
impairment due to AMD. The global estimate on AMD health-
care spending is US$255 billion [2]. AMD is a degenerative dis-
ease of  the central portion of  the retina, known as the macula, 
which results in loss of  central vision. Because central vision is 
required for a majority of  daily activities, it significantly impacts 
the functional status and quality of  life. In general, depending on 
the progression of  the disease, AMD is either characterized as 
dry type or wet type. The pathogenesis is currently poorly under-
stood; however, ischemia and oxidative stress are believed to be 
the key factors involved. This hypoxia state results in the release 
of  factors such as Vascular Endothelial Growth Factor (VEGF), 
and inflammatory signals, which help the growth of  new and ab-
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Abstract
Purpose: An estimated 19.3% of  adults, especially the elderly in the United States regularly use Aspirin for cardioprotec-
tion. Recently, multiple cohort studies have concluded that regular aspirin use for 10-15 years was associated with a statisti-
cally significant increase in the risk of  incident age-related and neovascular acute macular degeneration. It has been hypoth-
esized that aspirin or its metabolites induce the expression of  vascular endothelial growth factor (VEGF). 
Materials & Methods: Retinal pigment epithelial cells, ARPE-19 (ATCC®CRL-2302™) were cultured. The cells were 
grown to achieve 95% confluence and then the media was changed. Cells cultured under blue light, red light, or darkness 
were subjected to a challenge with high dose aspirin (0.925 mg/dL), low dose aspirin (0.325 mg/dL), or hippuric acid (0.325 
mg/dL). Light was generated using 2 red or blue LEDs powered by 3v CR2032 batteries. The 24-well plate was incubated 
with or without drugs in blue light, red light or darkness at 37C for 16 hours. The supernatants were harvested, and VEGF 
was quantified. One-way ANOVA using Dunnett’s multiple comparison test was performed to analyze statistical signifi-
cance.
Results: Cells exposed to blue light or darkness and hippuric acid showed a statistically significant increase in VEGF secre-
tion (P=0.0012). However, cells exposed to red light with hippuric acid challenge showed no significant difference from the 
mean of  cells exposed to darkness and sham control. 
Conclusions: Retinal pigment epithelial cells challenged with oxidative stress provided by blue light or darkness in the pres-
ence of  hippuric acid increased VEGF secretion, suggesting a possible cause for neovascularization in age-related macular 
degeneration. RPE cells exposed to red light, known to abrogate oxidative stress, had decreased levels of  VEGF induction 
by hippuric acid.
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normal vessels [3]. (Figure 1) This is especially true when attempt-
ing to explain the pathogenesis of  wet type AMD, also known as 
choroidal neovascularization, because clinical observations show 
that there is growth of  new and abnormal vessels into the subreti-
nal space [4]. In particular, VEGF release due to retinal ischemia 
results in weaker vessels that grow behind the retina and under 
the macula. As a result of  these weaker walls, these vessels begin 
to leak blood and fluid, causing the macula to swell and eventu-
ally progressing to permanent damage of  central vision of  the 
eye. Several other etiologies have been discussed as well, such as 
the complement pathway, single nucleotide polymorphisms, mac-
rophages, etc [3]. In addition, there are also several risk factors 
for AMD, including, age(>50) [5, 6], smoking [7], family history 
[8], and cardiovascular disease [9]. AMD is considered to be a 
multifactorial disease in which several factors including oxidative 
damage, inflammatory reaction and abnormal immune responses 
may be involved [10-12]. The retinal stress may in part result from 
exposure of  the eye to visible blue light. The combination of  blue 
light exposure and low plasma concentrations of  antioxidants was 
found to be associated with the early stages of  AMD; further-
more, blue light exposure in middle age individuals might be more 
damaging than at younger ages, as per the results of  a recent Eu-
ropean Eye Study (EUROEYE) [13]. Recent reports indicate that 
our eyes are increasingly being exposed to light from light emit-
ting diodes (LED’s) and light of  video display terminals (VDT’s) 
which contain blue light [14]. The putative pathway of  blue LED 
light-induced retinal photoreceptor-derived cell damage is shown 
in Figure 1. Although blue light causes oxidative stress, red light is 
known to reduce oxidative stress [15].
Several studies have shown the association of  aspirin use with 
age-related macular degeneration [16]. Recently, a 15-year pro-
spective analysis of  data from an Australian population-based 
cohort study concluded that regular aspirin use was associated 
with a 2.5-fold greater risk of  incidental neovascular AMD, inde-
pendent of  a history of  cardiovascular disease or smoking [17]. 
An article by Klein, et al found that chronic use of  aspirin for at 
least 10 years increased the risk of  neovascular AMD [18]. It com-
ments on how aspirin’s mechanism of  action on retinal vessels 
may be different than the mechanism of  action responsible for 
cardioprotection. However, another study investigating the pos-
sible relationship of  aspirin and age-related macular degeneration 
concluded that the relationship between aspirin use and AMD 
could not be established [19]. Aspirin and hippuric acid, the gly-
cine conjugate of  benzoic acid, share common metabolites such 
as 2-3-dihydroxybenzoic acid and 3-hydroxybenzoic acid (Figure 
2). Furthermore, we based our experimental concentrations of  
aspirin on the average circulating level of  aspirin in plasma after 
regular dose of  aspirin.
Despite all the research so far, the mechanism of  how aspirin 
causes neovascularization is not clearly understood. Although, it 
is known that aspirin enhances choroidal neovascularization in 
the presence of  cell injury, it is not clear as to what causes cell 
injury or how retinal ischemia occurs. We hypothesize that while 
the cell is under oxidative stress and cell injury, aspirin and its 
toxic metabolites trigger VEGF expression leading to choroidal 
neovascularization.
Materials and Methods
ARPE-19 (ATCC® CRL-2302™) cells were kindly provided by 
Dr. Knepper. RPE cells were cultured in DMEM medium, 10% 
FBS, Penicillin, Streptomycin, Ciprofloxacin at 37°C, %5 CO2. 
RPE Cells were tyrpsinized and plated in a 24 well plate in a to-
tal of  500 µL of  DMEM at 40,000 cells/mL. This concentration 
was used because it allows for sustained proliferation. The cells 
were grown out to > 95% confluency in about 72 hours and then 
media was changed. Cells cultured in Blue light, red light, or dark-
ness, were exposed to either sham, 0.925 mg/dL of  aspirin (high 
dose), 0.325 mg/dL aspirin (low dose), 0.325 mg/dL hippuric 
acid. Light was generated using 2 red or 2 blue LED’s powered by 
3v CR2032 batteries attached to the inside of  a standard freezer 
box. In this way it was possible to keep the 24 well plates in dark-
ness, red light, or blue light for the period of  the experiment. 
The plates were incubated with or without drugs in blue light, 
red light, or no light overnight for 16 hours. The supernatants 
were harvested and VEGF was quantified using Quantikine ELI-
SA Human VEGF Immunoassay kit (R&D Systems, Inc.), as per 
manufactures directions. After the supernatants were collected, 
cells in each individual well were trypsinized, and live cells were 
counted manually using a hemocytometer. Live cells were identi-
fied by the presence of  an intact nucleus and cellular membrane 
under polarized light. Total supernatant protein concentration 
was determined using modified Lowry method. During analysis 
of  data, VEGF concentration was normalized to the total protein 
concentration. One-way ANOVA using Dunnett’s multiple com-
parison test was performed using GraphPad Prism.
Results
The supernatants of  ARPE-19 (ATCC® CRL-2302™ cells cul-
tured in Blue light, red light, or darkness, and exposed to either 
sham, 0.925 mg/dL of  aspirin (high dose), 0.325 mg/dL aspirin 
(low dose), 0.325 mg/dL hippuric acid were analyzed to deter-
mine the VEGF in triplicates. The data was statistically analyzed 
to determine the mean, standard deviations, and p-values.
Under Blue Light
Under the influence of  blue light, the low dose aspirin, high dose 
aspirin and hippuric acid expressed VEGF amounting to 97.83 ± 
5.6, 104.2 ± 7.5 and 114.7 ± 3.3 pg/ml respectively, when com-
pared to the sham control value of  105.79 ± 8.4 pg/ml. Cells ex-
posed to blue light and hippuric acid had higher levels of  VEGF 
expression compared to the darkness sham control and the low 
and high dose aspirin under similar conditions. (See Figure 3).
Under Darkness
Under the influence of  darkness, the low dose aspirin, and high 
dose aspirin expressed VEGF amounting to 98.2 ± 1.68, and 
100.7 ± 9.0 respectively when compared to a sham control value 
of  116.8 ± 3.1 pg/ml and a no light control value of  100.7 ± 7.3 
pg/ml. Cells exposed to darkness and hippuric acid had higher 
levels of  VEGF expression compared to the darkness sham con-
trol and the low and high dose aspirin under similar conditions 
(See Figure 3).
Under Red Light
Under the influence of  red light, low dose aspirin, high dose 
aspirin and hippuric acid expressed VEGF amounting to 101.7 
± 3.84, 96.0.3.8 and 100.8 ± 0.41 pg/ml when compared to the 
sham control value of  95.2 ± 5.9 pg/ml. Cells exposed to red light 
and hippuric acid did not show an increased induction of  VEGF 
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expression when compared to cells exposed to hippuric acid and 
blue light or darkness (See Figure 3).
Difference in survival of  RPE cells
There was no statistically significant difference in the number of  
live cells between any experimental group at the conclusion of  
the experiment as determined by manual hemocytometer count-
ing after they were trypsinized and collected (p=0.7274). (See sup-
plemental Figure).
Discussion
We selected Retinal Pigment Epithelial Cells (RPE) for the follow-
ing reasons. RPE cells play a critical role in the development and 
maintenance of  adjacent photoreceptors. These photoreceptors 
generate a number of  reactive oxygen species when exposed to 
light, and their proliferation is an important step in the patho-
genesis of  ocular diseases such as AMD. It is presumed that the 
metabolites of  hippuric acid induce the generation of  reactive 
oxygen species during metabolism as well as induce VEGF ex-
pression, leading to choroidal neovascularization. VEGF is a di-
Figure 1. The putative pathway of  blue LED light-induced retinal photoreceptor-derived cell damage [14]
(Courtesy: Kuse Y et al – Reproduced with kind permission from Dr. Hideaki Hara)
Blue LED light
Figure 2: Aspirin and its metabolites.
Links between Aspirin (1) metabolites (black arrows), with two potential metabolites (dashed black arrows) and benzoic 
acid (2) and hippuric acid (3) metabolites (blue arrows) reported to date in the literature. Metabolites originating from the 
benzoate degredation via hydroxylation pathway of  the human detoxification process are also represented (yellow arrows)
Iqbal O, et al., (2015) Aspirin and its Metabolites Enhance the Expression of  Vascular Endothelial Growth Factor in Retinal Pigment Epithelial Cell Cultures – Implica-
tions in the Pathophysiology of  Age-Related Macular Degeneration. Int J Ophthalmol Eye Res.  03(7), 115-120. 118
http://scidoc.org/IJOES.php
Figure 3. VEGF Secretion.
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Supplementary Table 1. Raw Data VEGF expression.
(pg VEGF/ mg protein) Trail 1 Trail 2 Trail 3 Average Stdev
Blue Sham 115.46613 101.667334 100.24127 105.791578 8.40869405
Blue Low Dose Aspirin 94.7225614 94.4619837 104.310345 97.83163 5.61224419
Blue High Aspirin 103.602129 97.005261 112.030075 104.212488 7.53098031
Blue Hippuric Acid 118.161018 114.538441 111.457117 114.718859 3.35559025
Red Sham 97.7408009 88.4605694 99.4295635 95.2103113 5.90611895
Red Low Dose Aspirin 100.873485 98.3948636 105.942857 101.737069 3.84738662
Red High Dose Aspirin 93.804262 100.436508 93.7777778 96.0061826 3.83679715
Red Hippuric Acid 100.750518 101.273378 100.452381 100.825426 0.4155931
Dark Sham 109.023268 94.7538337 98.7406533 100.839252 7.36255922
Dark Low Aspirin 97.9003705 96.8163265 100.118718 98.2784716 1.68335006
Dark High Aspirin 92.3864102 99.537415 110.340136 100.754654 9.0385464
Dark Hippuric Acid 119.28839 117.897727 113.314142 116.83342 3.12609537
Cells exposed to blue light or darkness and hippuric acid showed a statistically significant increase in VEGF secretion (P=0.0012) using 
an ordinary 1 way ANOVA.  However, cells exposed to red light with hippuric acid challenge showed no significant difference from the 
mean of  cells exposed to darkness and sham control.
Supplementary Figure. Live cell  counts after experiment.
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Graphs shown with  mean live cell count in thousand/mL (circle) and 95% confidence intervals. Ther is  no statistical significant dif-
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meric signaling glycoprotein (MolWt VEGF monomer 21 KDa 
and dimer 42 kDa) with a structural homology to platelet derived 
growth factor (PDGF) that stimulates the formation of  new 
blood vessels.
Under the influence of  blue light, hippuric acid expressed higher 
levels of  VEGF measuring 114.7 ± 3.3 pg/ml compared to the 
dark sham control value of  105.79 ± 8.4 pg/ml (P=0.0012), while 
the low and high dose aspirin did not show any significant change. 
These results clearly show that hippuric acid can induce increased 
VEGF expression under the influence of  blue light when com-
pared to darkness alone; Although not statistically significant, there 
was a trend demonstrating that cells exposed to hippuric acid and 
blue light had increased levels of  VEGF expression when com-
pared to cells exposed to blue light alone, low dose aspirin, and 
high dose aspirin. The same trend is observed in cells exposed to 
darkness, but not red light. Although hippuric acid (C6H5CON-
HCH2COOH) with a molecular weight of  179.18 Daltons is not 
a direct metabolite of  aspirin, the metabolites of  hippuric acid 
and benzoic acid are common to the metabolites of  aspirin (see 
Figure 2). It is possible that biodegradation of  either aspirin or 
hippuric acid may generate the same metabolite that can trigger 
the expression of  VEGF, particularly polyhydroxylated benzoic 
acids such as 2,3-dihydroxybenzoic acid. Furthermore, following 
toluene metabolism, hippuric acid, the glycine conjugate of  ben-
zoic acid could be generated in the body and later excreted in 
the urine. Measurement of  hippuric acid in urine could be used 
as a screening test for individuals exposed to toluene in the ab-
sence of  xylene and styrene [20, 21]. People may be exposed to 
styrene and xylene in the workplace. Furthermore, the ingestion 
of  sodium benzoate, a very common food preservative, salicylic 
acid or aspirin by anyone can generate the production of  hippuric 
acid. A careful history taken from patients with age-related macu-
lar degeneration may identify individuals exposed to aspirin, ben-
zoic acid, and other compounds such as styrene and xylene in the 
workplace. Interestingly, under the influence of  oxidative stress 
provided by blue light in this case, the levels of  induced VEGF 
expression may increase, causing neovascularization and result-
ing in macular degeneration. It is interesting to note how blue 
light causes oxidative stress and contributes to the development 
of  macular degeneration. Recent reports show that light emitting 
diode blue light can damage photoreceptor cells in culture [14]. 
Given that human eyes are increasingly exposed to light emitted 
from the light emitting diode (LED) of  video display terminals 
(VDT) containing blue light, it is quite obvious that the patho-
genesis of  AMD progresses with retinal photic injury caused by 
excessive light exposure resulting in oxidative stress [22, 23]. Per-
haps, increased reactive oxygen species is a cellular mechanism 
that provides a possible explanation to the clinically observed 
phenomenon of  asthenopia, which is commonly referred to as 
eye fatigue, after long periods of  exposure to LED blue light or 
VDT blue light. Kuse Y, et al recently demonstrated that in vitro 
exposure to blue LED light damaged the 661 W cells and that 
this damage was associated with rapid ROS increase, NF-ĸB acti-
vation, P38 activation, ERK ½ inactivation, S-opsin aggregation 
and activated caspase-3/7, and autophagy [14] (see Figure 1). In 
our study, although we did not measure apoptotic or autophagic 
activity, hippuric acid in the presence of  blue light and darkness 
induced increased expression of  VEGF, suggestive of  its role in 
wet AMD.
Our study is the first study which provides evidence of  increased 
expression of  VEGF due to the effects of  hippuric acid and 
its metabolites. Under the influence of  red light, the low dose, 
high dose aspirin and hippuric acid groups expressed lower lev-
els of  VEGF compared to the values under blue light. Red light 
is known to reduce oxidative stress. Recently, red was reported 
to reduce oxidative stress and preserve function in central nerv-
ous system tissue vulnerable to secondary degeneration following 
partial transection of  the optic nerve [15]. In our study, hippuric 
acid in the presence of  red light did not induce the expression of  
VEGF, suggesting that decreased oxidative stress minimizes or 
has a palliative effect on the development of  AMD. Furthermore, 
it is shown that hippuric acid by itself  causes increased oxidative 
stress and that blue light is unable to rescue this oxidative effect; 
however, red light is able to rescue this oxidative effect, as evi-
denced by decreased VEGF secretion. Although we have tested 
aspirin and hippuric acid, future experiments could assess the ef-
fects of  other metabolites such as 2-3-dihydroxybenzoic acid and 
other hydroxybenoic acids that are common metabolites to both 
aspirin and hippuric acid. Clinically, the next rational approach 
is to show increased VEGF expression in patients taking aspirin 
who have developed AMD.
Even though we did not perform assays to quantify activation 
of  apoptotic cellular machinery, we were able to show that there 
is a non-statistically significant difference in the number of  cells 
surviving exposure to low dose aspirin, high dose aspirin, and 
hippuric acid under blue light, red light, or in darkness. These 
data suggest that exposure to blue light, red light, darkness, low 
dose aspirin, high dose aspirin, and hippuric acid did not have 
an effect on the survival of  RPE cells after 16 hours. Perhaps, 
there was no difference in gross survival of  RPE cells due to the 
short time frame of  the experiment. Alternatively, similar rates 
of  cell survival by the end of  the assay could also have been due 
to the total number of  reactive oxygen species not being enough 
to saturate anti-oxidative biochemical pathways, therefore permit-
ting cell survival. Future studies could utilize more sensitive assays 
to quantify the degree of  apoptosis and generation of  reactive 
oxygen species for an extended period of  time under similar ex-
perimental conditions.
Conclusion
Hippuric acid causes a statistically significant increased induction 
of  VEGF secretion in RPE cells exposed to blue light or dark-
ness, suggestive of  a cause for neovascularization in age-related 
macular degeneration due to common metabolites of  aspirin and 
hippuric acid. Red light, known to abrogate oxidative stress, did 
not have an increased induction of  VEGF secretion from basal 
levels when exposed to hippuric acid. Caution should be exercised 
in prescribing aspirin to vulnerable populations under increased 
oxidative stress. The results of  this study provide a clear ration-
ale for the use of  anti-VEGF therapy, such as bevacizumab and 
ranibizumab for slowing the progression of  neovascular AMD, 
especially in patients who have been exposed to aspirin for long 
periods of  time. Further large-scale clinical studies are warranted 
in order to validate these results.
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